Study in American Journal of Medicine Points to Zinc to Combat COVID, and HCQ for ‘Reduced Mortality’

AHA Publisher — Mon, 08 Feb 2021 08:00:38 +0000

Benjamin Gill via CBN News – These days, the primary message about fighting COVID-19 from the mainstream media is about wearing a mask. But there are also some proactive steps that people can take to strengthen their immune system in order to fight or mitigate the impact of a COVID infection. As we know, COVID is in the same family of viruses as the common cold – they’re both types of coronavirus. There have been many attempts to find a means of fighting the common cold, and one of them has been through zinc supplements. Now a study in the American Journal of Medicine confirms zinc could also be a good way to combat COVID. “Zinc is a known inhibitor of coronavirus replication,” the study states. “Clinical trials of zinc lozenges in the common cold have demonstrated modest reductions in the duration and or severity of symptoms.” “By extension, this readily available nontoxic therapy could be deployed at the first signs of COVID-19,” the researchers note. “Zinc lozenges can be administered 5 times a day for up to 5 days and extended if needed if symptoms persist.” “The amount of elemental zinc lozenges is <25% of that in a single 220-mg zinc sulfate daily tablet. This dose of zinc sulfate has been effectively used in combination with antimalarials in the early treatment of high-risk outpatients with COVID-19,” the study explains. Dr. Josh Axe tells CBN News he recommends zinc along with several other supplements to boost your immunity and fight COVID. “I recommend getting zinc, around 30 milligrams a day, Vitamin D at 5,000 IUs a day and Vitamin C at 1,000 milligrams a day,” he said. Dr. Axe also supports using herbal supplements to boost immunity during the pandemic. “I really like Echinacea because of how it strengthens the lungs, elderberry because of how it fights viruses, and astragalus for its immune-boosting properties,” he said. Meanwhile, the study in the American Journal of Medicine also cites antimalarial medications like Hydroxychloroquine (HCQ) as a potential early treatment, saying they can work in tandem with zinc to prevent replication of the virus within the human body. “HCQ is also a zinc ionophore that conveys zinc intracellularly to block the SARS-CoV-2 RNA-dependent RNA polymerase, which is the core enzyme of the virus replication,” the study states. That’s a lot of medical terminologies, but basically, it means HCQ and zinc can work together to stop the virus from growing inside an infected person. The researchers point out that retrospective studies and randomized trials show that HCQ is not effective if someone has an advanced case of COVID. But, “when started earlier in the hospital course, for progressively longer durations, and in outpatients, antimalarials may reduce the progression of the disease, prevent hospitalization, and are associated with reduced mortality,” the study says. Meanwhile, another new study by Hackensack Meridian Health also shows there may be a benefit to using HCQ for certain COVID patients. Of course, doctors are the only ones who should prescribe medications like Hydroxychloroquine, evaluating the specific risks and needs for each person. There has been a concern in the medical community that HCQ could cause heart arrhythmias for certain individuals. Consult with your doctor before making decisions about drugs or supplements. MUST SEE Super Sanitizing in the Age of COVID: Can You Be Too Clean? To read the original article click here. For more articles from CBN News click here.

The post Study in American Journal of Medicine Points to Zinc to Combat COVID, and HCQ for ‘Reduced Mortality’ appeared first on Amazing Health Advances.

COVID Doc Says Hydroxychloroquine ‘Highly Effective’ and Fears Are Overblown – Now FDA Chief Admits It Might Help

AHA Publisher — Sat, 01 Aug 2020 07:00:10 +0000

Lori Johnson via CBN News – A Tennessee physician has a message for COVID-19 patients: Use hydroxychloroquine “if you can find a doctor with guts enough to prescribe it.” Meanwhile, the US Food and Drug Commissioner Stephen Hahn said some studies “suggest a benefit” to using the drug on COVID-19, despite the fact that the government agency issued guidance stating the use of the drug should be avoided unless it’s being studied in a clinical trial or for hospital use. In a radio interview, Hahn reiterated the fact that doctors are free to prescribe the drug “off label,” and that the FDA “does not regulate the practice of medicine.” Dr. Tom Rogers is one of those physicians who prescribe hydroxychloroquine to his COVID-19 patients. He told CBN News he personally has found the drug to be a “highly effective” way to treat the virus, provided the drug is prescribed in the early stages of the disease and is combined with the antibiotic azithromycin and a zinc supplement. “It’s a very controversial, kind of ‘Trump drug’,” he told CBN News. “There were initially a bunch of studies that said it worked, and then the powers that be came out with some other studies that said it didn’t work. But there are many, many studies and many doctors who I’ve talked to personally, on the front lines that use it all the time and it works.” He continued, “You have to use it very early,” he said. “The studies that said it didn’t work, those were hospitalized patients that were very sick.” He said possible negative consequences of taking hydroxychloroquine are over-blown. “They’re claiming it causes cardiac arrhythmia, which is rare,” he says. “I’ve never seen that. I’ve talked to rheumatologists who’ve used it for decades, they’ve never seen it.” Dr. Rogers says he prefers to prescribe the hydroxychloroquine cocktail to patients with symptoms such as fever, aches, loss of taste or smell, and believes it can prevent a patient from going to the hospital. In addition to hydroxychloroquine combined with azithromycin and zinc, Dr. Rogers said there are other ways patients in the early stages of COVID-19 can avoid landing in the hospital. Those include the inhaled steroid Budesonide combined with azithromycin and zinc. Budesonide is a common asthma drug he prescribes to patients who test positive for COVID-19 and have mild respiratory symptoms such as “cough, wheezing or shortness of breath that’s not acute yet.” Still, neither hydroxychloroquine nor budesonide is recommended by the FDA to treat COVID-19 because their effectiveness has not been proven in randomized, controlled studies, which is the standard requirement for FDA approval. To read the original article click here. For more articles from CBN News click here.

The post COVID Doc Says Hydroxychloroquine ‘Highly Effective’ and Fears Are Overblown – Now FDA Chief Admits It Might Help appeared first on Amazing Health Advances.

zince Archives - Amazing Health Advances

Study in American Journal of Medicine Points to Zinc to Combat COVID, and HCQ for ‘Reduced Mortality’

COVID Doc Says Hydroxychloroquine ‘Highly Effective’ and Fears Are Overblown – Now FDA Chief Admits It Might Help